NCT03897400

Ovarian Reserve in Crohn's Disease

Evaluation of Ovarian Reserve in Crohn's Disease

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 100 (actual)
• Sponsor: Kanuni Sultan Suleyman Training and Research Hospital · Academic / Other
• Sex: Female
• Age: 18 Years – 40 Years
• Healthy volunteers: Accepted

Summary

Crohn's disease reduces fertility by inducing inflammation both directly and in the fallopian tubes and ovaries and indirectly through surgical interventions and tubal adhesions associated with disease treatment. Anti-mullerian hormone (AMH) is a reliable indicator of ovarian reserve in women. The aim of this study was to compare serum AMH levels in women with Crohn's disease and healthy controls. In this study, the investigators aimed to investigate AMH and ovarian capacity in the study group with crohn's disease and in the control group without disease.

Conditions

• Crohn Disease
• Ovary Disease
• Anti-Mullerian Hormone Deficiency

Interventions

Type	Name	Description
OTHER	AMH levels in young women with crohn's disease will be considered.	Ovarian Reserve in Young Women of Reproductive Age with Crohn's Disease;Blood will be taken from both the study and control groups and the AMH level will be evaluated.

Timeline

• Start date: 2019-03-01
• Primary completion: 2019-09-01
• Completion: 2019-09-01
• First posted: 2019-04-01
• Last updated: 2019-10-23

Locations

1 site across 1 country: Turkey (Türkiye)